Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in August, 2018 for $299,994.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA217486-01A1 | Phase I | 299,994 | August 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in May, 2020 for $399,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA246945-01A1 | Phase I | 399,999 | May 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in September, 2018 for $299,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA233122-01A1 | Phase I | 299,999 | September 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Stemsynergy Therapeutic in September, 2021 for $945,599.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA261490-01A1 | Phase II | 945,599 | September 1, 2021 | |||||||
A SBIR Phase II contract was awarded to Stemsynergy Therapeutic in September, 2019 for $1,375,997.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA228840-02 | Phase II | 1,375,997 | September 11, 2019 | |||||||
A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in March, 2018 for $297,882.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA228840-01 | Phase I | 297,882 | March 15, 2018 | |||||||
A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in April, 2022 for $399,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA268456-01A1 | Phase I | 399,999 | April 5, 2022 | |||||||
A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in September, 2016 for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM119408-01A1 | Phase I | 225,000 | September 16, 2016 | |||||||
A SBIR Phase II contract was awarded to Stemsynergy Therapeutic in September, 2017 for $2,999,979.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA144177-04A1 | Phase II | 2,999,979 | September 1, 2017 | |||||||
A SBIR Phase II contract was awarded to Stemsynergy Therapeutic in September, 2014 for $1,499,974.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA171489-02 | Phase II | 1,499,974 | September 16, 2014 | |||||||
A STTR Phase I contract was awarded to Stemsynergy Therapeutic in March, 2015 for $224,991.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA196011-01A1 | Phase I | 224,991 | March 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in September, 2016 for $224,968.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA200408-01A1 | Phase I | 224,968 | September 5, 2016 | |||||||
A STTR Phase I contract was awarded to Stemsynergy Therapeutic in March, 2015 for $224,991.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA196011-01A1 | Phase I | 224,991 | March 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Stemsynergy Therapeutic for $259,451.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA171489-01 | Phase I | 259,451 | ||||||||
A SBIR Phase I contract was awarded to Stemsynergy Therapeutic for $140,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA144177-01A1 | Phase I | 140,000 | ||||||||
A SBIR Phase II contract was awarded to Stemsynergy Therapeutic for $1,999,997.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA144177-02 | Phase II | 1,999,997 | ||||||||
A SBIR Phase II contract was awarded to Stemsynergy Therapeutic in September, 2023 for $939,827.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA268456-02 | Phase II | 939,827 | September 22, 2023 |